CSRC approves Huiko's application for IPO listing on the Shenzhen Stock Exchange main board.
On March 13, the China Securities Regulatory Commission issued the "Reply on Approving the Initial Public Offering of Shares Registration of Huicotech Co., Ltd."
On March 13, the China Securities Regulatory Commission issued the "Approval for the First Public Offering of Shares by Huike Limited Company." It is reported that Huike Limited plans to list on the Shenzhen Stock Exchange main board, with China International Capital Corporation as its sponsor, aiming to raise 8.5 billion yuan.
According to the prospectus, Huike Limited is a technology company specializing in the semiconductor display field, with its main business being research, development, manufacturing, and sales of core display devices such as semiconductor display panels and smart display terminals.
The company's main products include a variety of sizes and types of TV panels, IT panels, TV terminals, IT terminals, and various smart IoT terminals, widely used in consumer electronics, commercial displays, automotive electronics, industrial control, smart IoT, and other display scenarios.
Data from Qunzhi Consulting shows that in 2024, the company ranked third in the world in terms of TV panel shipments, fourth in display panel shipments, and third in smartphone panel shipments. In 2024, the company ranked first in the world in terms of shipments of 85-inch LCD TV panels, demonstrating a significant leading advantage in the field of 85-inch and larger ultra-large display panels.
Related Articles

Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!
Two big events on the eve of SpaceX's listing: Starship test flight postponed, IPO bundled with Grok AI sparking discussions.

Boji Medical Technology (300404.SZ) subsidiary Danyuan Diabetic Ointment has obtained the approval notice for drug clinical trials.

Evening hot topics on A-share market | Nine government departments jointly issued a document with 64 measures to boost consumption!

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


